>From THE JERUSALEM POST DAILY INTERNET EDITION
http://www.jpost.com:80/com/Archive/30.Jan.1997/Business/Article-2.html
FDA approves two Teva drugs
By JENNIFER FRIEDLIN
TEL AVIV (January 30) -- The US Food and Drug
Administration has given approval for Teva
Pharmaceutical Industries Ltd. to market and sell
its drugs for Wilson's and Parkinson's disease, the
company said yesterday.
The FDA approved Teva's Galzin drug, an original
drug designed to treat people suffering from
Wilson's disease, a rare, inherited disorder that
causes copper to accumulate in the liver and can
lead to neurological disorders and death.
Galzin is Teva's second original drug to receive
FDA approval. Copaxone, Teva's multiple sclerosis
drug, received approval at the end of 1996.
The FDA also approved Selegiline, a generic version
of Eldepryl, which treats Parkinson's disease, a
progressive nervous disorder that causes muscle
tremors and stilted movement in the elderly
Galzin has orphan drug status, meaning that the FDA
will not grant approval for a similar drug during
the next seven years. The status is granted for
drugs that treat diseases affecting less than
200,000 people in order to encourage drug
manufacturers to invest in research for treatments
of rare diseases.
Meanwhile, Dan Suesskind, chief financial officer
of Teva, said that he is not aware of the company's
plans to build a drug factory in Russia.
The Ha'aretz daily yesterday reported that Teva
will participate in building a $20 million factory
in Russia.
-------------------------------
Excerpt from CSS Internet News ,-~~-.____
For subscription details email / | ' \
[log in to unmask] with ( ) 0
SUBINFO CSSINEWS in the \_/-, ,----'
subject line. ==== //
/ \-'~; /~~~(O)
"On the Internet no one / __/~| / |
knows you're a dog" =( _____| (_________|
-------------------------------
